Joel Lewis
CEO, President at Galectin Therapeutics Inc (GALT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $621K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 6SEC | GALTGalectin Therapeutics Inc | Sell Plan | 18,571898,021 held (−2%) | $4.20 | $78K | -6.2% |
| Jan 6SEC | GALTGalectin Therapeutics Inc | Sell Plan | 27,731870,290 held (−3%) | $3.91 | $108K | +0.8% |
| Jan 6SEC | GALTGalectin Therapeutics Inc | Sell Plan | 37,698832,592 held (−4%) | $3.58 | $135K | +10.1% |
| Dec 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 7,829832,592 held (−1%) | $7.06 | $55K | -44.2% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 15,680832,592 held (−2%) | $6.04 | $95K | -34.8% |
| Nov 19SEC | GALTGalectin Therapeutics Inc | Sell Plan | 6,783832,592 held (−1%) | $6.15 | $42K | -35.9% |
| Nov 12SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,867832,592 held (−0%) | $6.03 | $11K | -34.7% |
| Nov 7SEC | GALTGalectin Therapeutics Inc | Sell Plan | 200832,592 held (−0%) | $6.00 | $1K | -34.3% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 1,300832,592 held (−0%) | $6.01 | $8K | -34.4% |
| Nov 5SEC | GALTGalectin Therapeutics Inc | Sell Plan | 14,420832,592 held (−2%) | $6.07 | $88K | -35.1% |
- Sell
CEO, President Joel Lewis sold $78K of GALT at $4.20 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joel Lewis sold $108K of GALT at $3.91 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joel Lewis sold $135K of GALT at $3.58 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joel Lewis sold $55K of GALT at $7.06 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joel Lewis sold $95K of GALT at $6.04 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Joel Lewis sold $42K of GALT at $6.15 — pre-scheduled 10b5-1 plan sale.